# DUAL Antithrombotic Therapy in Patients With AF and ACS

> **NCT04023630** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 4000 (estimated)

## Conditions studied

- Atrial Fibrillation
- Acute Coronary Syndromes

## Interventions

- **DRUG:** Rivaroxaban 15 MG Oral Tablet
- **DRUG:** Clopidogrel 75 Mg Oral Tablet
- **DRUG:** Ticagrelor 90 MG Oral Tablet

## Key facts

- **NCT ID:** NCT04023630
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2019-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023630, "DUAL Antithrombotic Therapy in Patients With AF and ACS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04023630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*